摘要
The infusion of chimaeric antigen receptor (CAR) T cells can trigger the release of life-threatening supraphysiological levels of pro-inflammatory cytokines. However, uncertainty regarding the timing and severity of such cytokine release syndrome (CRS) demands careful monitoring of the conditions required for the administration of neutralizing antibodies. Here we show that a temperature-sensitive hydrogel conjugated with antibodies for the pro-inflammatory cytokine interleukin-6 (IL-6) and subcutaneously injected before the infusion of CAR-T cells substantially reduces the levels of IL-6 during CRS while maintaining the therapy's antitumour efficacy. In immunodeficient mice and in mice with transplanted human haematopoietic stem cells, the subcutaneous IL-6-adsorbing hydrogel largely suppressed CAR-T-cell-induced CRS, substantially improving the animals' survival and alleviating their levels of fever, hypotension and weight loss relative to the administration of free IL-6 antibodies. The implanted hydrogel, which can be easily removed with a syringe following a cooling-induced gel-sol transition, may allow for a shift in the management of CRS, from monitoring to prevention. @@@ A subcutaneously injected hydrogel conjugated with antibodies for interleukin-6 substantially reduces the levels of the cytokine during chimaeric antigen receptor T-cell therapy while maintaining its antitumour efficacy.
- Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacyGu, Chengyuan; Wu, Qian; Zhang, Jingren; Kang, Liqing; Yu, Lei; Qiu, Huiying; Wu, Depei; Chen, Suning; Yang, Xiaofei*LEUKEMIA & LYMPHOMA, 2023, 64(2): 495-498.被引 3
- Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategiesXiao, Xinyi; Huang, Shengkang; Chen, Sifei; Wang, Yazhuo; Sun, Qihang; Xu, Xinjie*; Li, Yuhua*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40(1): 367.被引 60
- Promoting the Recruitment, Engagement, and Reinvigoration of Effector T Cells via an Injectable Hydrogel with a Supramolecular Binding Capability for Cancer ImmunotherapyZhu, Yueqiang; Jin, Liangjie; Chen, Junbin; Su, Miao; Sun, Tianmeng; Yang, Xianzhu*Advanced Materials, 2023.被引 1
